Fig. 10From: Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patientsChanges in the total plasma level of RA concentration on treatment days 1, 8 and 15 of a continuous treatment period with daily dose of 110 \( \frac{mg}{m^2} \) RA [57]Back to article page